Sort
11,323 grants matching “glioblastoma”
GENETIC NEUROCARCINOGEN RISKS &OUTCOMES FOR BRAIN TUMOR
$325,677Duke University · P50 · FY2004 · CA
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
$325,631Matthew L Meyerson · Dana-Farber Cancer Inst · R01 · FY2006 · CA
Understanding Mechanisms of Resistance to Anti-angiogenic Treatments
$325,626Ali Syed Arbab · Henry Ford Health System · R01 · FY2012 · CA
OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC
$325,621Andrew T Parsa · University Of California, San Francisco · P50 · FY2014 · CA
Using Cell-Penetrant Peptides to Target ATF5 in Mouse Glioma Models
$325,389James M Angelastro · University Of California At Davis · R01 · FY2016 · NS
Therapeutically Exploiting a Newly Isolated Neural-like Stem Cell Against GBM
$325,246Akiva Mintz · Wake Forest University Health Sciences · R01 · FY2015 · CA
Therapeutically Exploiting a Newly Isolated Neural-like Stem Cell Against GBM
$325,246Akiva Mintz · Wake Forest University Health Sciences · R01 · FY2016 · CA
Regulatory T Cells in Malignant Glioma
$325,170Maciej S Lesniak · University Of Chicago · R01 · FY2009 · CA
Neural Progenitor Genes and Brain Tumors
$325,085Harley I Kornblum · University Of California Los Angeles · R01 · FY2013 · NS
Characterization of tetraspanin-EWI protein complexes and functions
$325,000Martin E Hemler · Dana-Farber Cancer Inst · R01 · FY2008 · GM
The role of microvesicles in giloma virotherapy
$324,975E. Antonio Chiocca · Massachusetts General Hospital · P01 · FY2015 · CA
HEF1 Coordination of Cell Cycle, Migration, and Invasion in Cancer
$324,971Erica A Golemis · Research Inst Of Fox Chase Can Ctr · R01 · FY2012 · CA
UNS: Developing Quantitative Models of SHP2-Mediated Signaling regulation in Glioma for Rational Identification of Improved Therapeutic Approaches.
$324,956Matthew J Lazzara · University Of Pennsylvania · · FY2015 · ENG
Regulation of a DNA damage response network in glioblastoma
$324,948Andy J Minn · University Of Pennsylvania · R01 · FY2014 · CA
Novel DNA damage response inhibitor and alkylator combinations for GBM
$324,910Ranjit Bindra · Mayo Clinic Rochester · U19 · FY2024 · CA
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
$324,863Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2019 · CA
Investigating Novel Functions for NIK/MAP3K14 in High-Grade Glioma
$324,844Raquel Sitcheran · Texas A&M University Health Science Ctr · R01 · FY2021 · NS
The Fn14 Receptor and Brain Tumor Invasion
$324,844Jeffrey A Winkles · University Of Maryland Baltimore · R01 · FY2007 · NS
The Fn14 Receptor and Brain Tumor Invasion
$324,844Jeffrey A Winkles · University Of Maryland Baltimore · R01 · FY2009 · NS
Investigating Novel Functions for NIK/MAP3K14 in High-Grade Glioma
$324,844Raquel Sitcheran · Texas A&M University Health Science Ctr · R01 · FY2022 · NS
Investigating Novel Functions for NIK/MAP3K14 in High-Grade Glioma
$324,844Raquel Sitcheran · Texas A&M University Health Science Ctr · R01 · FY2018 · NS
Investigating Novel Functions for NIK/MAP3K14 in High-Grade Glioma
$324,844Raquel Sitcheran · Texas A&M University Health Science Ctr · R01 · FY2019 · NS
The Fn14 Receptor and Brain Tumor Invasion
$324,844Jeffrey A Winkles · University Of Maryland Baltimore · R01 · FY2008 · NS
Investigating Novel Functions for NIK/MAP3K14 in High-Grade Glioma
$324,844Raquel Sitcheran · Texas A&M University Health Science Ctr · R01 · FY2020 · NS
Novel Targeted Therapeutics for Cental Nervous System Malignancies
$324,799Francis Ali-Osman · Duke University · R01 · FY2007 · CA